Loncom Pharma's Desloratadine APIs are at the forefront of allergy treatment, providing a non-sedating option for allergy sufferers. These APIs are used in the formulation of medications that combat a variety of allergic reactions, offering a superior safety profile and effectiveness in controlling symptoms like sneezing, runny nose, and itchy eyes.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
